Strunz U T, Thompson M R, Elashoff J, Grossman M I
Gastroenterology. 1978 Mar;74(3):550-3.
In dogs with gastric fistulae and with transposition of the portal vein and the inferior vena cava, we studied secretion of acid in response to portal or systemic venous infusion of a series of progressively longer fragments of the carboxyl terminal portion of human gastrin. Pentagastrin, G6, G7, G8, G9, G10, G13, G17, and G34 were studied. Potency by portal venous infusion relative to systemic venous infusion was used as an index of hepatic inactivation. Fragments with eight or fewer amino acid residues were more than 90% inactivated by hepatic transit. Fragments with nine or more amino acid residues were more resistant to hepatic inactivation than shorter fragments. For fragments with 7 to 17 amino acid residues, increasing the chain length was accompanied by progressive increase both in hepatic resistance to inactivation and in potency for stimulation of acid secretion, suggesting that resistance to hepatic inactivation may be a major determinant of potency.
在患有胃瘘以及门静脉和下腔静脉转位的狗身上,我们研究了在门静脉或体静脉输注一系列逐渐延长的人胃泌素羧基末端片段后胃酸的分泌情况。研究了五肽胃泌素、G6、G7、G8、G9、G10、G13、G17和G34。门静脉输注相对于体静脉输注的效力被用作肝脏灭活的指标。氨基酸残基为八个或更少的片段在肝脏转运过程中被灭活超过90%。九个或更多氨基酸残基的片段比短片段对肝脏灭活更具抗性。对于具有7至17个氨基酸残基的片段,链长增加伴随着肝脏对灭活的抗性和刺激胃酸分泌的效力逐渐增加,这表明对肝脏灭活的抗性可能是效力的主要决定因素。